BGT vs PBFS

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a concerning lack of Altman Z-Score data, which limits bankruptcy risk assessment. Despite a high dividend yield of 12.53%, the unsustainable 165.9% payout ratio and declining earnings raise serious concerns about distribution coverage. Profitability margins are exceptionally high, but negative revenue and earnings growth, combined with a bearish technical trend, suggest underlying operational deterioration. The stock trades above the Graham Number of $15.44 at $11.55, implying potential overvaluation relative to defensive value standards despite weak fundamentals.

PBFS presents a valuation paradox: it trades below both its Graham Number ($15.74) and Intrinsic Value ($24.48), yet exhibits significant fundamental weakness. The Piotroski F-Score of 3/9 indicates a 'Weak' health status, suggesting deteriorating financial quality despite strong YoY revenue (15.7%) and earnings (16.8%) growth. Bearish insider sentiment and a 0/100 technical trend further dampen the outlook, offsetting the attractive Price-to-Book ratio of 1.06.